On April 13, 2026, Aimed Alliance sent a letter to New York Senator Rivera and Assemblymember Paulin regarding the proposed reforms to the federal 340B drug pricing program. Aimed Alliance’s letter urged the Legislature to pursue 340B transparency and reporting requirements that mandate covered entities disclose (1) 340B revenue; (2) how 340B Program revenue is used toward charity care, community benefits, or other types of unreimbursed care; and (3) the extent to which 340B savings are passed through to patients at the point of sale.
Read the letter on NY 340B reform.
Last Updated on July 22, 2026 by Aimed Alliance
